Skip to main content

Breadcrumb

  1. Home

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

Molecular and Genomic Profiling of Head and Neck Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Molecular and Genomic Profiling of Head and Neck Tumors

Collection of Samples and Data for the National Marrow Donor Program Repository

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Collection of Samples and Data for the National Marrow Donor Program Repository

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 265
  • Page 266
  • Page 267
  • Page 268
  • Page 269
  • Page 270
  • Page 271
  • Page 272
  • Page 273
  • Next page Next
  • Last page Last
Subscribe to